Wearable drug delivery device baseplate

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top perspective view of a wearable drug delivery device baseplate in accordance with an embodiment of the present invention;

FIG. 2 is a bottom perspective view of the drug delivery device baseplate;

FIG. 3 is a top plan view of the drug delivery device baseplate;

FIG. 4 is a left side elevational view of the drug delivery device baseplate;

FIG. 5 is a right side elevational view of the drug delivery device baseplate;

FIG. 6 is a front elevational view of the drug delivery device baseplate;

FIG. 7 is a back elevational view of the drug delivery device baseplate; and,

FIG. 8 is a bottom plan view of the drug delivery device baseplate.

Claims

The ornamental design for a wearable drug delivery device baseplate, as shown and described.

Referenced Cited
U.S. Patent Documents
5665065 September 9, 1997 Colman et al.
5816779 October 6, 1998 Lawless et al.
5913180 June 15, 1999 Ryan
6006239 December 21, 1999 Bhansali et al.
6589229 July 8, 2003 Connelly et al.
6656147 December 2, 2003 Gertsek et al.
6656148 December 2, 2003 Das et al.
6685675 February 3, 2004 Hadvary et al.
6740059 May 25, 2004 Flaherty
6824529 November 30, 2004 Gross et al.
6843782 January 18, 2005 Gross et al.
7052251 May 30, 2006 Nason et al.
D564087 March 11, 2008 Yodfat et al.
D574016 July 29, 2008 Yodfat et al.
D577118 September 16, 2008 Yodfat et al.
7517440 April 14, 2009 Anex et al.
7648494 January 19, 2010 Kornerup et al.
7660615 February 9, 2010 VanAntwerp
7678079 March 16, 2010 Shermer et al.
7708717 May 4, 2010 Estes et al.
D619245 July 6, 2010 Moga
7771391 August 10, 2010 Carter
7802923 September 28, 2010 Arnold et al.
7857131 December 28, 2010 Vedrine
7922708 April 12, 2011 Estes et al.
7927306 April 19, 2011 Cross et al.
7927325 April 19, 2011 Bright
7931621 April 26, 2011 Cross
D638534 May 24, 2011 Moga
7938801 May 10, 2011 Hawkins
7976500 July 12, 2011 Adams et al.
8062253 November 22, 2011 Nielsen et al.
8062256 November 22, 2011 Carter et al.
8114064 February 14, 2012 Alferness et al.
8128596 March 6, 2012 Carter
8128597 March 6, 2012 Cross et al.
8162923 April 24, 2012 Adams et al.
8226606 July 24, 2012 Adams et al.
8226607 July 24, 2012 Carter et al.
8231572 July 31, 2012 Carter et al.
8231577 July 31, 2012 Carter et al.
8267921 September 18, 2012 Yodfat et al.
8337486 December 25, 2012 Yodfat et al.
8352041 January 8, 2013 Das et al.
8361030 January 29, 2013 Carter
8409151 April 2, 2013 Hawkins et al.
8414563 April 9, 2013 Kamen et al.
D681830 May 7, 2013 Chung
8449504 May 28, 2013 Carter et al.
D684685 June 18, 2013 Schneider et al.
D684686 June 18, 2013 Cronenberg
D685083 June 25, 2013 Schneider et al.
D685084 June 25, 2013 Guarraia et al.
8469920 June 25, 2013 Mernoe et al.
D687140 July 30, 2013 Guarraia et al.
D687141 July 30, 2013 Schneider et al.
8491529 July 23, 2013 Yodfat et al.
D687536 August 6, 2013 Guarraia et al.
D688784 August 27, 2013 Schneider et al.
8500692 August 6, 2013 Yodfat et al.
8512287 August 20, 2013 Cindrich et al.
8613719 December 24, 2013 Karratt et al.
8753310 June 17, 2014 Sullivan et al.
8753315 June 17, 2014 Alferness et al.
8758308 June 24, 2014 Alferness et al.
8795230 August 5, 2014 Schoonmaker et al.
8795234 August 5, 2014 Kadamus et al.
8808269 August 19, 2014 Bazargan et al.
D744095 November 24, 2015 Winter
D747456 January 12, 2016 Sonderegger et al.
D747457 January 12, 2016 Glace et al.
D747458 January 12, 2016 Sonderegger et al.
D747459 January 12, 2016 Sonderegger et al.
9254373 February 9, 2016 Hardum
D754842 April 26, 2016 Sonderegger et al.
D754843 April 26, 2016 Sonderegger et al.
D756504 May 17, 2016 Sonderegger et al.
9364606 June 14, 2016 Cindrich et al.
9433757 September 6, 2016 Constantineau et al.
9480792 November 1, 2016 Constantineau et al.
9522229 December 20, 2016 Sonderegger et al.
9522231 December 20, 2016 Schneider et al.
D776284 January 10, 2017 Ratto
D777331 January 24, 2017 Jayalath
D778434 February 7, 2017 Arami
D780912 March 7, 2017 Babbs
20050238507 October 27, 2005 DiIanni et al.
20060183984 August 17, 2006 Dobbles et al.
20070282269 December 6, 2007 Carter et al.
20070287960 December 13, 2007 Adams et al.
20070299408 December 27, 2007 Alferness et al.
20080119790 May 22, 2008 Hawkins et al.
20080167641 July 10, 2008 Hansen et al.
20080249473 October 9, 2008 Rutti et al.
20090088692 April 2, 2009 Adams et al.
20090182277 July 16, 2009 Carter
20090240240 September 24, 2009 Hines et al.
20090247982 October 1, 2009 Krulevitch et al.
20090281497 November 12, 2009 Kamen et al.
20100049128 February 25, 2010 McKenzie et al.
20100167385 July 1, 2010 Celentano et al.
20100204657 August 12, 2010 Yodfat et al.
20100234805 September 16, 2010 Kaufmann et al.
20110098652 April 28, 2011 Hasted et al.
20110282293 November 17, 2011 Hordum
20110306931 December 15, 2011 Kamen et al.
20110319862 December 29, 2011 Friedman et al.
20120053522 March 1, 2012 Yodfat et al.
20120150115 June 14, 2012 Kamen et al.
20120209241 August 16, 2012 Drew
20120215175 August 23, 2012 Alferness et al.
20130072872 March 21, 2013 Yodfat et al.
20130226092 August 29, 2013 Hawkins et al.
20140088504 March 27, 2014 King
20140148756 May 29, 2014 Yodfat et al.
20140236086 August 21, 2014 Levesque et al.
20140236087 August 21, 2014 Alderete, Jr. et al.
20150065959 March 5, 2015 Carter et al.
20150292779 October 15, 2015 Chen
Foreign Patent Documents
101801438 August 2013 CN
103394143 November 2013 CN
WO-2009013736 January 2009 WO
WO-2009045780 April 2009 WO
WO-2009117466 September 2009 WO
WO-2015199981 December 2015 WO
Other references
  • PAQ®, a Simple 3-Day Basal/Bolus Insulin Delivery Device, for People with Type 2 Diabetes, CeQur Corporation, Abstract from ATTD 2016, 9th International Conference on Advanced Technologies & Treatments for Diabetes, Milan, Italy—Feb. 3-6, 2016, 1 page.
  • Human Factor Testing Provided Valuable Input into the Iterative Optimization of PAQ®, CeQur Corporation, Abstract from ATTD 2016, 9th International Conference on Advanced Technologies & Treatments for Diabetes, Milan, Italy—Feb. 3-6, 2016, 1 page.
  • Validation of Adhesive Tape Optimization of PAQ®, a Simple 3-Day Wearable Basal/Bolus Insulin Delivery Device, in Normal Volunteers, CeQur Corporation, Abstract from ATTD 2016, 9th International Conference on Advanced Technologies & Treatments for Diabetes, Milan, Italy—Feb. 3-6, 2016, 1 page.
  • PAQ®, a Simple 3-Day Wearable Basal/Bolus Insulin Delivery Device, Designed for Discreet Diabetes Management, CeQur Corporation, Abstract from ATTD 2016, 9thInternational Conference on Advanced Technologies & Treatments for Diabetes, Milan, Italy—Feb. 3-6, 2016, 1 page.
Patent History
Patent number: D829894
Type: Grant
Filed: Jan 21, 2016
Date of Patent: Oct 2, 2018
Assignee: BECTON, DICKINSON AND COMPANY (Franklin Lakes, NJ)
Inventors: Charles George Hwang (Wellesley, MA), John Prudden (Manchester, MA), Christopher Kovalchick (Bedford, MA), Russell Cole (River Vale, NJ), Nir Swenson (Somerville, MA), Gail Siewiorek (Winchester, MA), Joseph Iskandar (Brighton, MA), Alessandro Pizzochero (Chelmsford, MA)
Primary Examiner: David Muller
Application Number: 29/552,336
Classifications
Current U.S. Class: Element Or Attachment (19) (D24/127)